Latest From Skadden

  • A Guide to Redacting Commercially Sensitive Information From Exhibits Filed With the SEC
    Skadden, Arps, Slate, Meagher & Flom LLP
    Brian V. Breheny, Andrew J. Brady, Hagen J. Ganem, Josh LaGrange, Ryan J. Adams, Caroline S. Kim, Justin A. Kisner
    Amended rules requiring material agreements to be filed as exhibits to reports and registration statements with the SEC now permit the redaction of immaterial and commercially sensitive terms from filed agreements without a confidential treatment request. This guide outlines the amended rules and the process companies should follow to prevent the public disclosure of information redacted from their exhibits.
  • Trump Administration Limits US Purchase and Use of Certain Technology From Foreign Adversaries, Sale of US Technology to Huawei
    Skadden, Arps, Slate, Meagher & Flom LLP
    Michael E. Leiter, Ivan A. Schlager, Donald L. Vieira, Jonathan M. Gafni, Daniel J. Gerkin, Katherine A. Clarke, Nathan L. Mitchell
    Two new Trump two initiatives are aimed at addressing U.S. national security risks arising from the use of non-U.S. technology generally, with a particular focus on Huawei.
  • A Caution for Retrospective Merger Reviews
    New York Law Journal
    Karen Hoffman Lent, Kenneth B. Schwartz
    Partners Karen Hoffman Lent and Kenneth Schwartz discuss retrospective merger studies and why the FTC should limit its use of them.